DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
Reduced expression of the uptake transporter, OCTN1 (SLC22A4), has been reported as a strong predictor of poor event‐free and overall survival in multiple cohorts of patients with acute myeloid leukemia (AML) receiving the cytidine nucleoside analog, cytarabine (Ara‐C). To further understand the mec...
Wedi'i Gadw mewn:
Prif Awduron: | Daelynn R. Buelow (Awdur), Jason T. Anderson (Awdur), Stanley B. Pounds (Awdur), Lei Shi (Awdur), Jatinder K. Lamba (Awdur), Shuiying Hu (Awdur), Alice A. Gibson (Awdur), Emily A. Goodwin (Awdur), Alex Sparreboom (Awdur), Sharyn D. Baker (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Wiley,
2021-01-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice
gan: Jason T. Anderson, et al.
Cyhoeddwyd: (2019) -
Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia
gan: Joana Pereira-Vieira, et al.
Cyhoeddwyd: (2024) -
Standard dose Cytarabine-Induced Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Report
gan: Mehrshad Ebrahimpour, et al.
Cyhoeddwyd: (2024) -
High-dose cytarabine associated hemorrhagic pericardial effusion in a child with acute myeloid leukemia
gan: Swati Kapoor, et al.
Cyhoeddwyd: (2020) -
Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
gan: Tomislav Smoljo, et al.
Cyhoeddwyd: (2023)